Transjugular biopsy in patients with combined renal and liver disease: Making every organ count

American Journal of Kidney Diseases

Volumn 37, Issue 6, 2001, Pages 1304-1307

  Abbott, Kevin C ^a   Yuan, Christina M ^a   Batty, Donald S ^b   Lane, John D ^c   Stiles, Kevin P ^d  

^a Department of Internal Medicine   (United States)

^b Liver Transplantation   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EDITORIAL; HEPATORENAL SYNDROME; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; LIVER FAILURE;

EID: 0035016198     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.25167     Document Type: Article

References (33)

1. Pathogenesis, natural history, treatment, and prevention of hepatitis C
2. Cirrhotic glomerulonephritis: An underdiagnosed condition
3. Is there a hepatitis C virus-associated membranoproliferative glomerulonephritis?
4. The role of hepatitis C virus infection in glomerulopathy
5. Membranous nephropathy associated with hepatitis B virus infection: Long-term clinical and histological outcome
6. Glomerulonephritis associated with hepatitis C virus infection after renal transplantation
7. The kidney in liver transplantation
8. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
9. Hepatorenal syndrome: Combined liver kidney transplants versus isolated liver transplant
10. Hepatorenal syndrome - Outcome after liver transplantation
11. Liver transplantation for dialysis dependent hepatorenal failure
12. Combined liver and kidney transplantation in children
13. The kidney in liver transplantation
14. The role of combined liver/kidney transplantation in endstage hepato-renal disease
15. Single-center experience of combined liver and kidney transplantation
16. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure
17. Hepatorenal syndrome
18. Renal biopsy in high-risk patients with medical diseases of the kidney
19. Transjugular renal biopsy
20. Liver biopsy through the transjugular approach. Modification of instruments
21. Transjugular liver biopsy in high-risk patients with hepatic disease
22. Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities
23. The clinical efficacy of transjugular renal biopsy
24. Transjugular renal biopsy in patients with liver disease
25. Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: Comparison of sampling effectiveness and complications
26. Impact of donor and recipient hepatitis C virus infection status on outcomes after renal transplantation
27. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival
28. Special issues related to transplantation in Hong Kong
29. Hepatitis C virus genotypes in patients on renal replacement therapy
30. Current status of viral hepatitis and HIV transmission in renal transplant recipients: A study in Southeast Asia
31. Renal transplantation in hepatitis B surface antigen-positive patients: Single-center experience in Korea
32. Current status of interventional radiology in China
33. Current status of angiography and interventional radiology in Japan: Survey results